← All trials
NCT04565483
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2020
- Primary completion
- Mar 31, 2024
- Completion date
- Apr 30, 2024
- First posted
- Sep 25, 2020
- Last posted
- Dec 14, 2020
- Enrollment
- 220
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of NantesLead sponsor
- AstraZenecaCollaborator
- Government of FranceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.